Randi E. Foraker

Randi E. Foraker

Auto-generated profile, based on publicly available information

Randi E. Foraker

University of Missouri Columbia Health Care: MU Health Care

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2022 in Circulation
Verified
Journal Article
Closed access
PDF file
DLDonald M Lloyd-Jones
Donald M Lloyd-Jones
HNHongyan Ning
Hongyan Ning
DLDarwin Labarthe
Darwin Labarthe
LBLaPrincess C. Brewer
LaPrincess C. Brewer
GSGarima Sharma
Garima Sharma
APAmanda M. Perak
Amanda M. Perak
Background: The American Heart Association (AHA) recently published an updated algorithm for quantifying cardiovascular health (CVH)—the "Life's Essential 8™" score. We quantified US levels of CVH using the new score. Methods: We included non-pregnant, non-institutionalized individuals ages 2 through 79 years who were free of cardiovascular disease from the National Health and Nutrition Examination Surveys in 2013-2018. For all participants, we calculated the overall CVH score (range 0 [lowest] to 100 [highest]), as well as the score for each component of diet, physical activity (PA), nicotine exposure, sleep duration, body mass index (BMI), blood lipids, blood glucose, and blood pressure (BP), using published AHA definitions. Sample weights and design were incorporated in calculating prevalence estimates and standard errors using standard survey procedures. CVH scores were assessed across strata of age, sex, race/ethnicity, family income, and depression. Results There were 23,409 participants, representing 201,728,000 adults and 74,435,000 children. The overall mean CVH score was 64.7 (95% confidence interval [CI], 63.9-65.6) among adults using all 8 metrics, and it was 65.5 (95% CI, 64.4-66.6) for the 3 metrics available (diet, PA, and BMI) among children/adolescents ages 2 through 19 years. For adults, there were significant differences in mean overall CVH scores by sex (women: 67.0 vs. men: 62.5), age (range of mean values 62.2-68.7), and racial/ethnic group (range 59.7-68.5). Mean scores were lowest for diet, PA, and BMI metrics. There were large differences in mean scores across demographic groups for diet (range 23.8-47.7), nicotine exposure (range 63.1-85.0), blood glucose (range 65.7-88.1) and BP (range 49.5-84.0). In children, diet scores were low (mean 40.6) and were progressively lower in higher age groups (from 61.1 at ages 2-5 to 28.5 at ages 12-19); large differences were also noted in mean PA (range 63.1-88.3) and BMI (range 74.4-89.4) scores by sociodemographic group. Conclusions: The new Life's Essential 8 score helps identify large group and individual differences in CVH. Overall CVH in the US population remains well below optimal levels, and there are both broad and targeted opportunities to monitor, preserve, and improve CVH across the life course in both individuals and the population.

30 June 2023 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
ALAbigail E Lewis
Abigail E Lewis
NWNicole Weiskopf
Nicole Weiskopf
ZAZachary B Abrams
Zachary B Abrams
RFRandi Foraker
Randi Foraker
ALAlbert M Lai
Albert M Lai
AGAditi Gupta
Aditi Gupta
Objective: We extended a 2013 literature review on electronic health record (EHR) data quality assessment approaches and tools to determine recent improvements or changes in EHR data quality assessment methodologies. Materials and Methods: We completed a systematic review of PubMed articles from 2013 to April 2023 that discussed the quality assessment of EHR data. We screened and reviewed papers for the dimensions and methods defined in the original 2013 manuscript. We categorized papers as data quality outcomes of interest, tools, or opinion pieces. We abstracted and defined additional themes and methods though an iterative review process. Results: We included 103 papers in the review, of which 73 were data quality outcomes of interest papers, 22 were tools, and 8 were opinion pieces. The most common dimension of data quality assessed was completeness, followed by correctness, concordance, plausibility, and currency. We abstracted conformance and bias as 2 additional dimensions of data quality and structural agreement as an additional methodology. Discussion: There has been an increase in EHR data quality assessment publications since the original 2013 review. Consistent dimensions of EHR data quality continue to be assessed across applications. Despite consistent patterns of assessment, there still does not exist a standard approach for assessing EHR data quality. Conclusion: Guidelines are needed for EHR data quality assessment to improve the efficiency, transparency, comparability, and interoperability of data quality assessment. These guidelines must be both scalable and flexible. Automation could be helpful in generalizing this process.

1 May 2011 in Circulation: Heart Failure
Verified
Journal Article
Closed access
PDF file
RFRandi E. Foraker
Randi E. Foraker
KRKathryn M. Rose
Kathryn M. Rose
CSChirayath M. Suchindran
Chirayath M. Suchindran
PCPatricia P. Chang
Patricia P. Chang
AMAnn M. McNeill
Ann M. McNeill
WRWayne D. Rosamond
Wayne D. Rosamond
Background—: Among patients with heart failure (HF), early readmission or death and repeat hospitalizations may be indicators of poor disease management or more severe disease. Methods and Results—: We assessed the association of neighborhood median household income (nINC) and Medicaid status with rehospitalization or death in the Atherosclerosis Risk in Communities cohort study (1987 to 2004) after an incident HF hospitalization in the context of individual socioeconomic status and evaluated the relationship for modification by demographic and comorbidity factors. We used generalized linear Poisson mixed models to estimate rehospitalization rate ratios and 95% CIs and Cox regression to estimate hazard ratios (HRs) and 95% CIs of rehospitalization or death. In models controlling for race and study community, sex, age at HF diagnosis, body mass index, hypertension, educational attainment, alcohol use, and smoking, patients with a high burden of comorbidity who were living in low-nINC areas at baseline had an elevated hazard of all-cause rehospitalization (HR, 1.40; 95% CI, 1.10 to 1.77), death (HR, 1.36; 95% CI, 1.02 to 1.80), and rehospitalization or death (HR, 1.36; 95% CI, 1.08 to 1.70) as well as increased rates of hospitalization compared to those with a high burden of comorbidity living in high-nINC areas. Medicaid recipients with a low level of comorbidity had an increased hazard of all-cause rehospitalization (HR, 1.19; 95% CI, 1.05 to 1.36) and rehospitalization or death (HR, 1.21; 95% CI, 1.07 to 1.37) and a higher rate of repeat hospitalizations compared to non-Medicaid recipients. Conclusions—: Comorbidity burden appears to influence the association among nINC, Medicaid status, and rehospitalization and death in patients with HF.

21 October 2010 in BMC Public Health
Verified
Journal Article
Open access
PDF file
RFRandi E Foraker
Randi E Foraker
KRKathryn Rose
Kathryn Rose
EWEric A Whitsel
Eric A Whitsel
CSChirayath M Suchindran
Chirayath M Suchindran
JWJoy L Wood
Joy L Wood
WRWayne D Rosamond
Wayne D Rosamond
Pharmacologic treatments are efficacious in reducing post-myocardial infarction (MI) morbidity and mortality. The potential influence of socioeconomic factors on the receipt of pharmacologic therapy has not been systematically examined, even though healthcare utilization likely influences morbidity and mortality post-MI. This study aims to investigate the association between socioeconomic factors and receipt of evidence-based treatments post-MI in a community surveillance setting.

1 December 2020 in JAMIA Open
Verified
Journal Article
Open access
PDF file
RFRandi E Foraker
Randi E Foraker
SYSean C Yu
Sean C Yu
AGAditi Gupta
Aditi Gupta
AMAndrew P Michelson
Andrew P Michelson
JSJose A Pineda Soto
Jose A Pineda Soto
PPPhilip R O Payne
Philip R O Payne
Synthetic data may provide a solution to researchers who wish to generate and share data in support of precision healthcare. Recent advances in data synthesis enable the creation and analysis of synthetic derivatives as if they were the original data; this process has significant advantages over data deidentification. To assess a big-data platform with data-synthesizing capabilities (MDClone Ltd., Beer Sheva, Israel) for its ability to produce data that can be used for research purposes while obviating privacy and confidentiality concerns. We explored three use cases and tested the robustness of synthetic data by comparing the results of analyses using synthetic derivatives to analyses using the original data using traditional statistics, machine learning approaches, and spatial representations of the data. We designed these use cases with the purpose of conducting analyses at the observation level (Use Case 1), patient cohorts (Use Case 2), and population-level data (Use Case 3). For each use case, the results of the analyses were sufficiently statistically similar (P > 0.05) between the synthetic derivative and the real data to draw the same conclusions. This article presents the results of each use case and outlines key considerations for the use of synthetic data, examining their role in clinical research for faster insights and improved data sharing in support of precision healthcare.

1 February 2016 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
RFRandi E. Foraker
Randi E. Foraker
MAMahmoud Abdel-Rasoul
Mahmoud Abdel-Rasoul
LKLewis H. Kuller
Lewis H. Kuller
RJRebecca D. Jackson
Rebecca D. Jackson
LHLinda Van Horn
Linda Van Horn
HTHilary A. Tindle
Hilary A. Tindle